Asher Bio
ActiveWe build better immunotherapies
What it does
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.
Next to it in Healthcare and bio · precision immunotherapy platform
- Endpoint HealthY Combinator W19
Precision-first therapies
- PhrazeTechstars TS 2019
Phraze - Transforming the Healthcare
- Kernal BiologicsY Combinator S20
Kernal is creating mRNA 2.0 therapies that work in specific cells
- BioptamersSOSV SOSV IndieBio RebelBio 07
Personalized precision therapies
- Helix NanotechnologiesY Combinator W17
Next-generation mRNA platform to solve cancer, COVID and climate.
- Silene BiotechTechstars TS 2017
silenebiotech.com
- Organicin ScientificTechstars TS 2022
Organicin Scientific | Bacteriocins to Prevent Disease
- RyboDynSOSV SOSV IndieBio SF 15
Unlocking the dark proteome for high-resolution immunotherapies